Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 25

1.

Barcoding chemical modifications into nucleic acids improves drug stability in vivo.

Sago CD, Kalathoor S, Fitzgerald JP, Lando GN, Djeddar N, Bryksin AV, Dahlman JE.

J Mater Chem B. 2018 Nov 28;6(44):7197-7203. doi: 10.1039/c8tb01642a. Epub 2018 Aug 28.

2.

High-throughput in vivo screen of functional mRNA delivery identifies nanoparticles for endothelial cell gene editing.

Sago CD, Lokugamage MP, Paunovska K, Vanover DA, Monaco CM, Shah NN, Gamboa Castro M, Anderson SE, Rudoltz TG, Lando GN, Munnilal Tiwari P, Kirschman JL, Willett N, Jang YC, Santangelo PJ, Bryksin AV, Dahlman JE.

Proc Natl Acad Sci U S A. 2018 Oct 16;115(42):E9944-E9952. doi: 10.1073/pnas.1811276115. Epub 2018 Oct 1. Erratum in: Proc Natl Acad Sci U S A. 2018 Nov 27;115(48):E11427.

3.

Modifying a Commonly Expressed Endocytic Receptor Retargets Nanoparticles in Vivo.

Sago CD, Lokugamage MP, Lando GN, Djeddar N, Shah NN, Syed C, Bryksin AV, Dahlman JE.

Nano Lett. 2018 Dec 12;18(12):7590-7600. doi: 10.1021/acs.nanolett.8b03149. Epub 2018 Sep 20.

4.

Bacteria-Based Materials for Stem Cell Engineering.

Hay JJ, Rodrigo-Navarro A, Petaroudi M, Bryksin AV, GarcĂ­a AJ, Barker TH, Dalby MJ, Salmeron-Sanchez M.

Adv Mater. 2018 Oct;30(43):e1804310. doi: 10.1002/adma.201804310. Epub 2018 Sep 12.

PMID:
30209838
5.

Analyzing 2000 in Vivo Drug Delivery Data Points Reveals Cholesterol Structure Impacts Nanoparticle Delivery.

Paunovska K, Gil CJ, Lokugamage MP, Sago CD, Sato M, Lando GN, Gamboa Castro M, Bryksin AV, Dahlman JE.

ACS Nano. 2018 Aug 28;12(8):8341-8349. doi: 10.1021/acsnano.8b03640. Epub 2018 Jul 20.

6.

A Direct Comparison of in Vitro and in Vivo Nucleic Acid Delivery Mediated by Hundreds of Nanoparticles Reveals a Weak Correlation.

Paunovska K, Sago CD, Monaco CM, Hudson WH, Castro MG, Rudoltz TG, Kalathoor S, Vanover DA, Santangelo PJ, Ahmed R, Bryksin AV, Dahlman JE.

Nano Lett. 2018 Mar 14;18(3):2148-2157. doi: 10.1021/acs.nanolett.8b00432. Epub 2018 Mar 5.

7.

Conformational coupling of integrin and Thy-1 regulates Fyn priming and fibroblast mechanotransduction.

Fiore VF, Strane PW, Bryksin AV, White ES, Hagood JS, Barker TH.

J Cell Biol. 2015 Oct 12;211(1):173-90. doi: 10.1083/jcb.201505007.

8.

One primer to rule them all: universal primer that adds BBa_B0034 ribosomal binding site to any coding standard 10 BioBrick.

Bryksin AV, Bachman HN, Cooper SW, Balavijayan T, Blackstone RM, Du H, Jenkins JP, Haynes CL, Siemer JL, Fiore VF, Barker TH.

ACS Synth Biol. 2014 Dec 19;3(12):956-9. doi: 10.1021/sb500047r.

9.

Escherichia coli deletion mutants illuminate trade-offs between growth rate and flux through a foreign anabolic pathway.

Falls KC, Williams AL, Bryksin AV, Matsumura I.

PLoS One. 2014 Feb 4;9(2):e88159. doi: 10.1371/journal.pone.0088159. eCollection 2014.

10.

Learning from nature - novel synthetic biology approaches for biomaterial design.

Bryksin AV, Brown AC, Baksh MM, Finn MG, Barker TH.

Acta Biomater. 2014 Apr;10(4):1761-9. doi: 10.1016/j.actbio.2014.01.019. Epub 2014 Jan 24. Review.

11.

Functional analysis of Borrelia burgdorferi uvrA in DNA damage protection.

Sambir M, Ivanova LB, Bryksin AV, Godfrey HP, Cabello FC.

FEMS Microbiol Lett. 2011 Apr;317(2):172-80. doi: 10.1111/j.1574-6968.2011.02226.x. Epub 2011 Feb 17.

12.

Rational design of a plasmid origin that replicates efficiently in both gram-positive and gram-negative bacteria.

Bryksin AV, Matsumura I.

PLoS One. 2010 Oct 8;5(10):e13244. doi: 10.1371/journal.pone.0013244.

13.

Overlap extension PCR cloning: a simple and reliable way to create recombinant plasmids.

Bryksin AV, Matsumura I.

Biotechniques. 2010 Jun;48(6):463-5. doi: 10.2144/000113418.

14.

BmpA is a surface-exposed outer-membrane protein of Borrelia burgdorferi.

Bryksin AV, Tomova A, Godfrey HP, Cabello FC.

FEMS Microbiol Lett. 2010 Aug 1;309(1):77-83. doi: 10.1111/j.1574-6968.2010.02020.x. Epub 2010 May 20.

15.

Retraction. Localization of BmpA on the exposed outer membrane of Borrelia burgdorferi by monospecific anti-recombinant BmpA rabbit antibodies.

Shin JJ, Bryksin AV, Godfrey HP, Cabello FC.

Infect Immun. 2008 Oct;76(10):4792. doi: 10.1128/IAI.00922-08. No abstract available.

16.

Role of glyceraldehyde-3-phosphate dehydrogenase in vesicular transport from golgi apparatus to endoplasmic reticulum.

Bryksin AV, Laktionov PP.

Biochemistry (Mosc). 2008 Jun;73(6):619-25. Review.

PMID:
18620527
17.

Borrelia burgdorferi BmpA, BmpB, and BmpD proteins are expressed in human infection and contribute to P39 immunoblot reactivity in patients with Lyme disease.

Bryksin AV, Godfrey HP, Carbonaro CA, Wormser GP, Aguero-Rosenfeld ME, Cabello FC.

Clin Diagn Lab Immunol. 2005 Aug;12(8):935-40.

18.

Borrelia burgdorferi rel is responsible for generation of guanosine-3'-diphosphate-5'-triphosphate and growth control.

Bugrysheva JV, Bryksin AV, Godfrey HP, Cabello FC.

Infect Immun. 2005 Aug;73(8):4972-81.

19.

Genetic and physiological characterization of 23S rRNA and ftsJ mutants of Borrelia burgdorferi isolated by mariner transposition.

Morozova OV, Dubytska LP, Ivanova LB, Moreno CX, Bryksin AV, Sartakova ML, Dobrikova EY, Godfrey HP, Cabello FC.

Gene. 2005 Aug 29;357(1):63-72.

PMID:
16023305
20.

Borrelia burgdorferi binds to, invades, and colonizes native type I collagen lattices.

Zambrano MC, Beklemisheva AA, Bryksin AV, Newman SA, Cabello FC.

Infect Immun. 2004 Jun;72(6):3138-46.

22.

Construction of long DNA molecules using long PCR-based fusion of several fragments simultaneously.

Shevchuk NA, Bryksin AV, Nusinovich YA, Cabello FC, Sutherland M, Ladisch S.

Nucleic Acids Res. 2004 Jan 22;32(2):e19.

23.

Glyceraldehyde-3-phosphate dehydrogenase is responsible for intranuclear localization of some oligonucleotides.

Tomasi V, Laktionov PP, Bryksin AV, Volod'ko NV, Griffoni C, Rykova EY, Spisni E, Kraft R, Vlassov VV.

Nucleosides Nucleotides Nucleic Acids. 2001 Apr-Jul;20(4-7):863-7.

PMID:
11563133
24.

[Pharmacokinetics and stability in the blood in vivo of phosphodiester and modified oligonucleotide derivatives].

Laktionov PP, Bryksin AV, Rykova EIu, Amirkhanov NV, Vlasov VV.

Vopr Med Khim. 1999 May-Jun;45(3):206-15. Russian.

PMID:
10432555
25.

Interaction of oligonucleotides with barrier fluid proteins.

Laktionov PP, Rykova EYu, Krepkii DV, Bryksin AV, Vlassov VV.

Biochemistry (Mosc). 1997 Jun;62(6):613-8.

PMID:
9284542

Supplemental Content

Loading ...
Support Center